DURANTE ADESIVI UK LTD


2022-08-012023-07-312023-07-31false10280870DURANTE ADESIVI UK LTD2024-03-08iso4217:GBPxbrli:pure102808702022-08-01102808702023-07-31102808702022-08-012023-07-31102808702021-08-01102808702022-07-31102808702021-08-012022-07-3110280870bus:SmallEntities2022-08-012023-07-3110280870bus:AuditExempt-NoAccountantsReport2022-08-012023-07-3110280870bus:FullAccounts2022-08-012023-07-3110280870bus:PrivateLimitedCompanyLtd2022-08-012023-07-3110280870core:WithinOneYear2023-07-3110280870core:AfterOneYear2023-07-3110280870core:WithinOneYear2022-07-3110280870core:AfterOneYear2022-07-3110280870core:ShareCapital2023-07-3110280870core:SharePremium2023-07-3110280870core:RevaluationReserve2023-07-3110280870core:OtherReservesSubtotal2023-07-3110280870core:RetainedEarningsAccumulatedLosses2023-07-3110280870core:ShareCapital2022-07-3110280870core:SharePremium2022-07-3110280870core:RevaluationReserve2022-07-3110280870core:OtherReservesSubtotal2022-07-3110280870core:RetainedEarningsAccumulatedLosses2022-07-3110280870core:LandBuildings2023-07-3110280870core:PlantMachinery2023-07-3110280870core:Vehicles2023-07-3110280870core:FurnitureFittings2023-07-3110280870core:OfficeEquipment2023-07-3110280870core:NetGoodwill2023-07-3110280870core:IntangibleAssetsOtherThanGoodwill2023-07-3110280870core:ListedExchangeTraded2023-07-3110280870core:UnlistedNon-exchangeTraded2023-07-3110280870core:LandBuildings2022-07-3110280870core:PlantMachinery2022-07-3110280870core:Vehicles2022-07-3110280870core:FurnitureFittings2022-07-3110280870core:OfficeEquipment2022-07-3110280870core:NetGoodwill2022-07-3110280870core:IntangibleAssetsOtherThanGoodwill2022-07-3110280870core:ListedExchangeTraded2022-07-3110280870core:UnlistedNon-exchangeTraded2022-07-3110280870core:LandBuildings2022-08-012023-07-3110280870core:PlantMachinery2022-08-012023-07-3110280870core:Vehicles2022-08-012023-07-3110280870core:FurnitureFittings2022-08-012023-07-3110280870core:OfficeEquipment2022-08-012023-07-3110280870core:NetGoodwill2022-08-012023-07-3110280870core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3110280870core:ListedExchangeTraded2022-08-012023-07-3110280870core:UnlistedNon-exchangeTraded2022-08-012023-07-3110280870core:MoreThanFiveYears2022-08-012023-07-3110280870core:Non-currentFinancialInstruments2023-07-3110280870core:Non-currentFinancialInstruments2022-07-3110280870dpl:CostSales2022-08-012023-07-3110280870dpl:DistributionCosts2022-08-012023-07-3110280870core:LandBuildings2022-08-012023-07-3110280870core:PlantMachinery2022-08-012023-07-3110280870core:Vehicles2022-08-012023-07-3110280870core:FurnitureFittings2022-08-012023-07-3110280870core:OfficeEquipment2022-08-012023-07-3110280870dpl:AdministrativeExpenses2022-08-012023-07-3110280870core:NetGoodwill2022-08-012023-07-3110280870core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3110280870dpl:GroupUndertakings2022-08-012023-07-3110280870dpl:ParticipatingInterests2022-08-012023-07-3110280870dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-012023-07-3110280870core:ListedExchangeTraded2022-08-012023-07-3110280870dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-012023-07-3110280870core:UnlistedNon-exchangeTraded2022-08-012023-07-3110280870dpl:CostSales2021-08-012022-07-3110280870dpl:DistributionCosts2021-08-012022-07-3110280870core:LandBuildings2021-08-012022-07-3110280870core:PlantMachinery2021-08-012022-07-3110280870core:Vehicles2021-08-012022-07-3110280870core:FurnitureFittings2021-08-012022-07-3110280870core:OfficeEquipment2021-08-012022-07-3110280870dpl:AdministrativeExpenses2021-08-012022-07-3110280870core:NetGoodwill2021-08-012022-07-3110280870core:IntangibleAssetsOtherThanGoodwill2021-08-012022-07-3110280870dpl:GroupUndertakings2021-08-012022-07-3110280870dpl:ParticipatingInterests2021-08-012022-07-3110280870dpl:GroupUndertakingscore:ListedExchangeTraded2021-08-012022-07-3110280870core:ListedExchangeTraded2021-08-012022-07-3110280870dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-08-012022-07-3110280870core:UnlistedNon-exchangeTraded2021-08-012022-07-3110280870core:NetGoodwill2023-07-3110280870core:IntangibleAssetsOtherThanGoodwill2023-07-3110280870core:LandBuildings2023-07-3110280870core:PlantMachinery2023-07-3110280870core:Vehicles2023-07-3110280870core:FurnitureFittings2023-07-3110280870core:OfficeEquipment2023-07-3110280870core:AfterOneYear2023-07-3110280870core:WithinOneYear2023-07-3110280870core:ListedExchangeTraded2023-07-3110280870core:UnlistedNon-exchangeTraded2023-07-3110280870core:ShareCapital2023-07-3110280870core:SharePremium2023-07-3110280870core:RevaluationReserve2023-07-3110280870core:OtherReservesSubtotal2023-07-3110280870core:RetainedEarningsAccumulatedLosses2023-07-3110280870core:NetGoodwill2022-07-3110280870core:IntangibleAssetsOtherThanGoodwill2022-07-3110280870core:LandBuildings2022-07-3110280870core:PlantMachinery2022-07-3110280870core:Vehicles2022-07-3110280870core:FurnitureFittings2022-07-3110280870core:OfficeEquipment2022-07-3110280870core:AfterOneYear2022-07-3110280870core:WithinOneYear2022-07-3110280870core:ListedExchangeTraded2022-07-3110280870core:UnlistedNon-exchangeTraded2022-07-3110280870core:ShareCapital2022-07-3110280870core:SharePremium2022-07-3110280870core:RevaluationReserve2022-07-3110280870core:OtherReservesSubtotal2022-07-3110280870core:RetainedEarningsAccumulatedLosses2022-07-3110280870core:NetGoodwill2021-08-0110280870core:IntangibleAssetsOtherThanGoodwill2021-08-0110280870core:LandBuildings2021-08-0110280870core:PlantMachinery2021-08-0110280870core:Vehicles2021-08-0110280870core:FurnitureFittings2021-08-0110280870core:OfficeEquipment2021-08-0110280870core:AfterOneYear2021-08-0110280870core:WithinOneYear2021-08-0110280870core:ListedExchangeTraded2021-08-0110280870core:UnlistedNon-exchangeTraded2021-08-0110280870core:ShareCapital2021-08-0110280870core:SharePremium2021-08-0110280870core:RevaluationReserve2021-08-0110280870core:OtherReservesSubtotal2021-08-0110280870core:RetainedEarningsAccumulatedLosses2021-08-0110280870core:AfterOneYear2022-08-012023-07-3110280870core:WithinOneYear2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:CostValuation2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-08-012023-07-3110280870core:Non-currentFinancialInstrumentscore:CostValuation2023-07-3110280870core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-3110280870core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-3110280870core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-3110280870core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-3110280870core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-3110280870core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-3110280870core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-3110280870core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-3110280870core:Non-currentFinancialInstrumentscore:CostValuation2022-07-3110280870core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-07-3110280870core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-07-3110280870core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-07-3110280870core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-07-3110280870core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-07-3110280870core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-07-3110280870core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-07-3110280870core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-07-3110280870bus:Director12022-08-012023-07-31

DURANTE ADESIVI UK LTD

Registered Number
10280870
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2023

DURANTE ADESIVI UK LTD
Company Information
for the year from 1 August 2022 to 31 July 2023

Director

SEVILLE, James Lee

Registered Address

Linen Hall 162-168 Regent Street Room 252-254
London
W1B 5TB

Registered Number

10280870 (England and Wales)
DURANTE ADESIVI UK LTD
Balance Sheet as at
31 July 2023

Notes

2023

2022

£

£

£

£

Current assets
Debtors7001,341
Cash at bank and on hand1,5076,958
2,2078,299
Creditors amounts falling due within one year(6,759)(5,583)
Net current assets (liabilities)(4,552)2,716
Total assets less current liabilities(4,552)2,716
Net assets(4,552)2,716
Capital and reserves
Called up share capital22
Profit and loss account(4,554)2,714
Shareholders' funds(4,552)2,716
  • The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
  • The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
The financial statements were approved and authorised for issue by the Director on 8 March 2024, and are signed on its behalf by:
SEVILLE, James Lee
Director
Registered Company No. 10280870
DURANTE ADESIVI UK LTD
Notes to the Financial Statements
for the year ended 31 July 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20232022
Average number of employees during the year11